Skip to main content
Top
Published in: International Journal of Colorectal Disease 11/2019

01-11-2019 | Colectomy | Original Article

Epidemiology of and prognostic factors for appendiceal carcinomas: a retrospective, population-based study

Authors: Shaobo Mo, Zheng Zhou, Zhen Ying, Weixing Dai, Wenqiang Xiang, Lingyu Han, Qingguo Li, Renjie Wang, Guoxiang Cai

Published in: International Journal of Colorectal Disease | Issue 11/2019

Login to get access

Abstract

Background

The aim of this study is to evaluate the epidemiology of and prognostic factors for appendiceal carcinomas (ACs).

Methods

All cases of ACs registered in the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2014 were retrospectively identified in this study. Age-adjusted incidence and survival rates were calculated.

Results

We analyzed 7170 patients with ACs. We observed a significant increase in the reported annual age-adjusted incidence of ACs from 1973 (0.18/100,000) to 2014 (1.11/100,000). The elevation of the incidence was noted in all the histological types, stages, and grades. The most common histological type varied by race, with the appendiceal mucinous adenocarcinoma (AMA) being the most common in white, Asian/Pacific Islander, and American Indian/Alaskan Native patients, and the appendiceal adenocarcinoma (AA) being the most common in African American patients. In multivariate analysis of patients with all ACs, gender (P < 0.001), year of diagnosis (P < 0.001), age (P < 0.001), race (P < 0.001), tumor grade (P < 0.001), disease stage (P < 0.001), retrieved regional lymph nodes (P < 0.001), type of surgery performed (P = 0.002), and histologic subtype (P < 0.001) were predictors of outcome. Survival time for all ACs increased from the 1973–1993 period to the 1994–2014 period (HR 0.76; 95% CI, 0.69 to 0.85). Additionally, the 5-year survival rates were 88% for malignant carcinoid, 70% for goblet cell carcinoid, 51% for colonic type adenocarcinoma, 59% for mucinous adenocarcinoma, and 25% for signet ring cell type.

Conclusions

We observed increased reported incidence of ACs and increased survival durations over time, suggesting that clinicians pay more attention to ACs and mastering the characteristic of these tumors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. 68(1):7–30 Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. 68(1):7–30
2.
go back to reference Khan F, Vogel RI, Diep GK, Tuttle TM, Lou E (2016) Prognostic factors for survival in advanced appendiceal cancers. Cancer Biomark 17(4):457–462CrossRef Khan F, Vogel RI, Diep GK, Tuttle TM, Lou E (2016) Prognostic factors for survival in advanced appendiceal cancers. Cancer Biomark 17(4):457–462CrossRef
3.
go back to reference Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA (2008) Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol 34(2):196–201CrossRef Smeenk RM, van Velthuysen ML, Verwaal VJ, Zoetmulder FA (2008) Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol 34(2):196–201CrossRef
4.
go back to reference Deans GT, Spence RA (1995) Neoplastic lesions of the appendix. Br J Surg 82(3):299–306CrossRef Deans GT, Spence RA (1995) Neoplastic lesions of the appendix. Br J Surg 82(3):299–306CrossRef
5.
go back to reference McCusker ME, Cote TR, Clegg LX, Sobin LH (2002) Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998. Cancer. 94(12):3307–3312CrossRef McCusker ME, Cote TR, Clegg LX, Sobin LH (2002) Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998. Cancer. 94(12):3307–3312CrossRef
6.
go back to reference Noone AM, Lund JL, Mariotto A, Cronin K, McNeel T, Deapen D, Warren JL (2016) Comparison of SEER treatment data with Medicare claims. Med Care 54(9):e55–e64CrossRef Noone AM, Lund JL, Mariotto A, Cronin K, McNeel T, Deapen D, Warren JL (2016) Comparison of SEER treatment data with Medicare claims. Med Care 54(9):e55–e64CrossRef
7.
go back to reference Marmor S, Portschy PR, Tuttle TM, Virnig BA (2015) The rise in appendiceal cancer incidence: 2000-2009. J Gastrointest Surg 19(4):743–750CrossRef Marmor S, Portschy PR, Tuttle TM, Virnig BA (2015) The rise in appendiceal cancer incidence: 2000-2009. J Gastrointest Surg 19(4):743–750CrossRef
8.
go back to reference Buuren SV, Groothuis-Oudshoorn K (2011) Mice: multivariate imputation by chained equations in R. J Stat Softw 45:1–67CrossRef Buuren SV, Groothuis-Oudshoorn K (2011) Mice: multivariate imputation by chained equations in R. J Stat Softw 45:1–67CrossRef
9.
go back to reference Marshall A, Altman DG, Holder RL, Royston P (2009) Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Med Res Methodol 9:57CrossRef Marshall A, Altman DG, Holder RL, Royston P (2009) Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Med Res Methodol 9:57CrossRef
10.
go back to reference Kocher KE, Meurer WJ, Fazel R, Scott PA, Krumholz HM, Nallamothu BK (2011) National trends in use of computed tomography in the emergency department. Ann Emerg Med 58(5):452–62 e3CrossRef Kocher KE, Meurer WJ, Fazel R, Scott PA, Krumholz HM, Nallamothu BK (2011) National trends in use of computed tomography in the emergency department. Ann Emerg Med 58(5):452–62 e3CrossRef
11.
go back to reference Phillips KA, Liang SY, Ladabaum U, Haas J, Kerlikowske K, Lieberman D, Hiatt R, Nagamine M, Van Bebber SL (2007) Trends in colonoscopy for colorectal cancer screening. Med Care 45(2):160–167CrossRef Phillips KA, Liang SY, Ladabaum U, Haas J, Kerlikowske K, Lieberman D, Hiatt R, Nagamine M, Van Bebber SL (2007) Trends in colonoscopy for colorectal cancer screening. Med Care 45(2):160–167CrossRef
12.
go back to reference Benedix F, Reimer A, Gastinger I, Mroczkowski P, Lippert H, Kube R, Study Group Colon/Rectum Carcinoma Primary T (2010) Primary appendiceal carcinoma--epidemiology, surgery and survival: results of a German multi-center study. Eur J Surg Oncol 36(8):763–771CrossRef Benedix F, Reimer A, Gastinger I, Mroczkowski P, Lippert H, Kube R, Study Group Colon/Rectum Carcinoma Primary T (2010) Primary appendiceal carcinoma--epidemiology, surgery and survival: results of a German multi-center study. Eur J Surg Oncol 36(8):763–771CrossRef
13.
go back to reference Piso P, Bektas H, Werner U, Schlitt HJ, Kubicka S, Bornscheuer A, Manns M, Klempnauer J (2001) Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma. Eur J Surg Oncol 27(3):286–290CrossRef Piso P, Bektas H, Werner U, Schlitt HJ, Kubicka S, Bornscheuer A, Manns M, Klempnauer J (2001) Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma. Eur J Surg Oncol 27(3):286–290CrossRef
14.
go back to reference El Halabi H, Gushchin V, Francis J, Athas N, Macdonald R, Nieroda C, Studeman K, Sardi A (2012) The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. Ann Surg Oncol 19(1):110–114CrossRef El Halabi H, Gushchin V, Francis J, Athas N, Macdonald R, Nieroda C, Studeman K, Sardi A (2012) The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. Ann Surg Oncol 19(1):110–114CrossRef
15.
go back to reference Sugarbaker PH, Graves T, DeBruijn EA, Cunliffe WJ, Mullins RE, Hull WE, Oliff L, Schlag P (1990) Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res 50(18):5790–5794PubMed Sugarbaker PH, Graves T, DeBruijn EA, Cunliffe WJ, Mullins RE, Hull WE, Oliff L, Schlag P (1990) Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res 50(18):5790–5794PubMed
16.
go back to reference Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gomez Portilla A, de Hingh IH, Ceelen WP, Pelz JO, Piso P, Gonzalez-Moreno S, Van Der Speeten K, Morris DL (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30(20):2449–2456CrossRef Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gomez Portilla A, de Hingh IH, Ceelen WP, Pelz JO, Piso P, Gonzalez-Moreno S, Van Der Speeten K, Morris DL (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30(20):2449–2456CrossRef
Metadata
Title
Epidemiology of and prognostic factors for appendiceal carcinomas: a retrospective, population-based study
Authors
Shaobo Mo
Zheng Zhou
Zhen Ying
Weixing Dai
Wenqiang Xiang
Lingyu Han
Qingguo Li
Renjie Wang
Guoxiang Cai
Publication date
01-11-2019
Publisher
Springer Berlin Heidelberg
Published in
International Journal of Colorectal Disease / Issue 11/2019
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-019-03387-y

Other articles of this Issue 11/2019

International Journal of Colorectal Disease 11/2019 Go to the issue